Site Search
Professionals 255 results
Capabilities 61 results
Practice Area
Our Patent Litigation Practice is one of the country’s most active and highly regarded. Our seasoned patent litigators bring extensive courtroom experience to every matter we handle. According to Lex Machina, we are among the top three national patent defense firms in the country for number of appearances and cases filed, and we also were the top national defense firm for number of patent trials in the last five years (2018–2022).
Practice Area
The United States International Trade Commission (ITC) is an increasingly popular venue for patent infringement litigation. More and more companies are seeking to halt importations of infringing products into the United States by turning to the ITC for expedited relief. Section 337 investigations conducted by the ITC provide complainants with a “fast track” to remedy IP matters that typically go to trial within 10 months. Since many Section 337 cases go to trial, selecting an ITC litigation team with a command of the technology, patent law, and specialized procedural practice is extremely important. We have handled more than 100 cases before the ITC.
Practice Area
Winston’s Intellectual Property (IP) Practice is one of the most active and highly regarded in the United States per Chambers USA, Benchmark Litigation US, and Best Law Firms®, among other ranking organizations. Our team features some of the country’s best IP lawyers, attorneys with the technical abilities to litigate and try highly complex IP disputes, and technical lawyers who provide critical advisory services.
Experience 54 results
Experience
|August 18, 2025
Winston Represented Amphenol in Definitive Agreement to Acquire Trexon
Winston represented Amphenol Corporation (NYSE: APH), one of the world’s largest designers, manufacturers, and marketers of electrical, electronic, and fiber optic connectors and systems, as well as coaxial and high-speed specialty cables, in its definitive agreement to acquire Trexon, a leading provider of high-reliability interconnect and cable assemblies primarily serving the defense market. The acquisition is valued at approximately US$1B, subject to customary post-closing adjustments. Amphenol will finance the transaction with cash on hand and expects to close in the fourth quarter of 2025.
Experience
|June 25, 2025
Winston Secures Federal Circuit Affirmance of 101 Victory for Polycom
Winston secured an appellate victory for Polycom (now part of HP) when the Federal Circuit affirmed a judgment on the pleadings of patent-ineligibility in a lawsuit brought by directPacket Research, Inc. Working closely with HP, Winston argued that all claims of the asserted patent were directed to the abstract idea of translation via an intermediate protocol, with no inventive concept. The Northern District of California agreed, and the Federal Circuit unanimously affirmed, adopting Winston’s arguments. Eimeric Reig argued the appeal, working with HP and the Winston team, including Kathi Vidal, Kelly Hunsaker, Sam Lerner, Matt McCullough, and David Dalke.
Experience
|May 27, 2025
PicoCELA Inc. Closes $1.8 Public Offering
Winston & Strawn represented Revere Securities LLC acted as the lead placement agent in connection with PicoCELA, Inc. in the closing of its public offering of 6,100,000 American Depositary Shares ("ADSs") at a public placement price of $0.30 per ADS. PicoCELA, Inc. received an aggregate gross proceeds of $1.83 million before deducting placement agent commission and other offering expenses. Each ADS represents one common share of the Company.
Insights & News 2,213 results
Webinar
|December 17, 2025
Privacy Problems Webinar Series
Join the Winston & Strawn Global Privacy and Data Security Practice team for a conversation on emerging privacy trends to have on your radar as we approach the New Year. Topics will include a discussion of strategies companies can take to protect themselves against a wave of burgeoning claims under California’s Shine the Light Law, recent trends in wiretap lawsuits arising from online website monitoring and email tracking practices (hint: looking at you, Florida), and insights on why companies should pay close attention to commercial email subject lines sent to Washington recipients.
Product Liability & Mass Torts Digest
|December 9, 2025
|3 Min Read
From Credibility to Admissibility: Reblending the Expert Playbook Under Rule 702
The recent decision in Mendoza v. SharkNinja Operating, LLC by the District of Colorado offers a practical illustration of how federal courts are applying the heightened reliability standard under the 2023 amendments to Rule 702.
Tax Impacts
|December 4, 2025
|3 Min Read
On December 1, 2025, the U.S. House of Representatives passed two significant pieces of bipartisan legislation aimed at reforming tax administration and judicial review: the Fair and Accountable IRS Reviews (FAIR) Act (H.R. 5346) and the Tax Court Improvement Act (H.R. 5349).
Other Results 48 results
Site Content
In the product liability context, a design defect claim arises when a plaintiff alleges that a product is inherently dangerous due to its design, rendering it unreasonably unsafe for its intended use. This type of claim does not focus on manufacturing errors but instead asserts that the product's fundamental design flaw poses an unreasonable risk of harm to consumers.
Law Glossary
Colloquially referred to as the “patent dance,” the BPCIA provides a framework that includes certain steps and a schedule during which the applicant and reference product sponsor exchange confidential information disclosed in the aBLA. During the patent dance, the applicant and sponsor identify the patents that could be litigated in the future during two potential phases of litigation. In the first phase, the sponsor can allege infringement of a subset of the patents identified during the patent dance. The second phase begins after the sponsor receives the Notice of Commercial Marketing from the applicant. During this second phase, the sponsor can assert any remaining patents that were not asserted in the first phase.
Law Glossary
What Is the Patent Trial and Appeal Board?
The Patent Trial and Appeal Board (PTAB) is a tribunal within U.S. Patent and Trademark Office. The PTAB oversees trial proceedings, namely: inter partes review (IPR), post-grant review (PGR), covered business method (CBM) review, and derivation proceedings. The Board also hears appeals from adverse patentability decisions by patent examiners in original applications, reissues, and reexaminations. And, while phasing out since the passage of the America Invents Act (AIA) in 2011, the PTAB is also responsible for deciding interferences. The PTAB was previously referred to as the Board of Patent Appeals and Interferences and was renamed by the AIA.